Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia

Blood

Volumn 113, Issue 10, 2009, Pages 2284-2289

  De Jonge, Robert ^a   Tissing, Wim J E ^b,c   Hooijberg, Jan Hendrik ^d   Jansen, Gerrit ^d   Kaspers, Gertjan J L ^d   Lindemans, Jan ^a   Peters, Godefridus J ^d   Pieters, Rob ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID DERIVATIVE; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NICOTINAMIDE METHYLTRANSFERASE; REDUCED FOLATE CARRIER; THYMIDYLATE SYNTHASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLELE; ARTICLE; BLOOD DONOR; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 64049110710     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-165928     Document Type: Article

References (54)

1. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetra-hydrofolates in red blood cells. Proc Natl Acad Sci U S A. 1998;95:13217-13220.
2. Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst. 2004;96:134-144.
3. Etienne MC, Ilc K, Formento JL, et al. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. Br J Cancer. 2004;90:526-534.
4. Horie N, AibaH, Oguro K, Hojo H,Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5́-termi-nal regulatory region of the human gene for thy-midylate synthase. Cell Struct Funct. 1995;20:191-197.
5. Mauritz R, Beumer IJ, Marsh S, et al. Polymorphism of the thymidylate synthase gene and thy-midylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients. Nucleosides Nucleotides Nucleic Acids. 2004;23:1381-1384.
6. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem.1999;10:66-88.
7. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA.1997;94:3290-3295.
8. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632-4642.
9. Duthie SJ, Narayanan S, Brand GM, Pirie L Grant G. Impact of folate deficiency on DNAstability. J Nutr. 2002;132[suppl]:2444-2449.
10. Lucock M. Is folic acid the ultimate functional food component for disease prevention? BMJ. 2004;328:211-214.
11. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reduc-tase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A. 1999;96:12810-12815.
12. Matsuo K, Suzuki R, Hamajima N, et al. Association between polymorphisms of folate-and methi-onine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood. 2001;97:3205-3209.
13. Matsuo K, Hamajima N, Suzuki R, et al. Methyl-enetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol. 2004;77:351-357.
14. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF. Methylenetetrahy-drofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A. 2001;98:4004-4009.
15. Franco RF, Simoes BP, Tone LG, Gabellini SM, Zago MA, Falcao RP. The methylenetetrahydrofo-late reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol. 2001;115:616-618.
16. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004;103:252-257.
17. Robien K, Ulrich CM. 5,10-Methylenetetrahydro-folate reductase polymorphisms and leukemiarisk: a HuGE minireview. Am J Epidemiol. 2003;157:571-582.
18. Gemmati D, Ongaro A, Scapoli GL, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lym-phoma in adults. Cancer Epidemiol Biomarkers Prev. 2004;13:787-794.
19. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood. 2002;99:3786-3791.
20. Hishida A, Matsuo K, Hamajima N, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica. 2003;88:159-166.
21. de Jonge R, Hooijberg JH, van Zelst BD, et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood. 2005;106:717-720.
22. Chango A, Emery-Fillon N, de Courcy GP, et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab.2000;70:310-315.
23. Relton CL, Wilding CS, Pearce MS, et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet. 2004;41:256-260.
24. Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH. Interactions among polymorphisms in folate-metabolizing genes and serum total homocys-teine concentrations in a healthy elderly population. Am J Clin Nutr. 2006;83:708-713.
25. Whetstine JR, Gifford AJ, Witt T, et al. Single nu-cleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transportproperties of the His(27) and Arg(27) carriers. Clin Cancer Res. 2001;7:3416-3422.
26. Yates Z, Lucock M. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non ho-mocysteine related mechanism. Life Sci. 2005;77:2735-2742.
27. Belkov VM, Krynetski EY, Schuetz JD, et al. Reduced folate carrier expression in acute lympho-blastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood. 1999;93:1643-1650.
28. Zhang L, Taub JW, Williamson M, et al. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immuno-phenotype and ploidy. Clin Cancer Res. 1998;4:2169-2177.
29. Lightfoot TJ, Skibola CF, Willett EV, et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev. 2005;14:2999-3003.
30. Skibola CF, Forrest MS, Coppede F, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood.2004;104:2155-2162.
31. Relton CL, Wilding CS, Laffling AJ, et al. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab. 2004;81:273-281.
32. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine syn-thase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:2509-2516.
33. Gotze T, Rocken C, Rohl FW, et al. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett. 2007;251:228-236.
34. Coppede F, Colognato R, Migliore L. MTHFR and RFC-1 gene polymorphisms and the risk of Down syndrome in Italy. Am J Med Genet A. 2007;143:1018-1019.
35. Coppede F, Marini G, Bargagna S, et al. Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women. Am J Med Genet A. 2006;140:1083-1091.
36. Scala I, Granese B, Sellitto M, et al. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med. 2006;8:409-416.
37. Kishi S, Cheng C, French D, et al. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 2007;109:4151-4157.
38. Huang L, Tissing WJ, de Jonge R, van Zelst BD, Pieters R. Polymorphisms in folate-related genes:association with side effects of high-dose metho-trexate in childhood acute lymphoblastic leukemia. Leukemia. 2008;22:1798-1800.
39. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neo-plasia: a HuGE review. Am J Epidemiol. 2004;159:423-443.
40. PereiraTV, Rudnicki M, PereiraAC, Pombo-de-Oliveira MS, Franco RF. 5,10-Methylenetetrahy-drofolate reductase polymorphisms and acutelymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:1956-1963.
41. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lym-phoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358:1935-1940.
42. Aplenc R, Thompson J, Han P, et al. Methyl-enetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lympho-blastic leukemia. Cancer Res. 2005;65:2482-2487.
43. Boccia S, Hung R, Ricciardi G, et al. Meta-and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol. 2008;167:505-516.
44. Frosst P, Blom HJ, Milos R, et al. Acandidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
45. Kluijtmans LA, Boers GH, Trijbels FJ, van Lith-Zanders HM, van den Heuvel LP, Blom HJ. A common 844INS68 insertion variant in the cysta-thionine beta-synthase gene. Biochem Mol Med.1997;62:23-25.
46. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
47. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A->C polymorphism in methylenetetrahy-drofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis. 2001;156:409-415.
48. Weisberg I, Tran P, Christensen B, Sibani S,Rozen R. Asecond genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169-172.
49. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetra-hydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044-1051.
50. Lievers KJ, Boers GH, Verhoef P, et al. Asecond common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med. 2001;79:522-528.
51. Souto JC, Blanco-Vaca F, Soria JM, et al. A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet.2005;76:925-933.
52. RoesslerM, RollingerW, Palme S,et al. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin Cancer Res. 2005;11:6550-6557.
53. Sartini D, Santarelli A, Rossi V, et al. Nicotin-amide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Mol Med. 2007;13:415-421.
54. Rots MG, Pieters R, Peters GJ, et al. Role of folylpolyglutamate synthetase and folylpolygluta-mate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood. 1999;93:1677-1683. 2290-2297